247 related articles for article (PubMed ID: 30430637)
1. Nivolumab PD-1 inhibitor immunotherapy associated with vulvar, perineal and perianal lichen sclerosus.
Wernham AGH; Shah F; Velangi S
Clin Exp Dermatol; 2019 Mar; 44(2):e22-e23. PubMed ID: 30430637
[No Abstract] [Full Text] [Related]
2. Genital lichen sclerosus after nivolumab.
Miraglia E; Soda G; Giustini S
Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342187
[No Abstract] [Full Text] [Related]
3. Acute generalized exanthematous pustulosis associated with ipilimumab and nivolumab.
Page B; Borradori L; Beltraminelli H; Yawalkar N; Hunger RE
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e256-e257. PubMed ID: 28430376
[No Abstract] [Full Text] [Related]
4. Radiation recall dermatitis associated with nivolumab for metastatic malignant melanoma.
Korman AM; Tyler KH; Kaffenberger BH
Int J Dermatol; 2017 Apr; 56(4):e75-e77. PubMed ID: 28102540
[No Abstract] [Full Text] [Related]
5. No recurrence of nivolumab-induced idiopathic thrombocytopenic purpura in a metastatic melanoma patient switched to ipilimumab.
Takimoto R; Otsuka A; Kaku Y; Honda T; Kabashima K
Eur J Dermatol; 2018 Feb; 28(1):84-85. PubMed ID: 29400292
[No Abstract] [Full Text] [Related]
6. Subcutaneous Fat Necrosis During Nivolumab Therapy for Metastatic Melanoma.
Pach J; Olamiju B; Weiss S; Damsky W; Leventhal J
JAMA Dermatol; 2021 Apr; 157(4):468-469. PubMed ID: 33688919
[No Abstract] [Full Text] [Related]
7. Nivolumab-associated bullous pemphigoid reactions involving multiple epitopes.
Aoki Y; Miyagawa F; Miyashita K; Nishimura Y; Hashimoto T; Asada H
Eur J Dermatol; 2019 Oct; 29(5):552-554. PubMed ID: 31570326
[No Abstract] [Full Text] [Related]
8. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus.
Goldstein AT; Creasey A; Pfau R; Phillips D; Burrows LJ
J Am Acad Dermatol; 2011 Jun; 64(6):e99-104. PubMed ID: 21353334
[TBL] [Abstract][Full Text] [Related]
9. Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab in a patient with advanced malignant melanoma.
Wada N; Uchi H; Furue M
J Dermatol; 2017 Aug; 44(8):e196-e197. PubMed ID: 28391613
[No Abstract] [Full Text] [Related]
10. Secondary haemophagocytic lymphohistiocytosis due to checkpoint inhibitor therapy.
Chin CK; Hall S; Green C; Van Hazel G; Spagnolo D; Cheah CY
Eur J Cancer; 2019 Jul; 115():84-87. PubMed ID: 31129384
[No Abstract] [Full Text] [Related]
11. Isolated Adrenocorticotropic Hormone Deficiency in Melanoma Patients Treated with Nivolumab.
Kitano S; Tatsuno K; Ishibe J; Shimauchi T; Fujiyama T; Ito T; Ogawa N; Tokura Y
Acta Derm Venereol; 2018 Jul; 98(7):704-705. PubMed ID: 29405244
[No Abstract] [Full Text] [Related]
12. Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient.
Fujimura T; Kambayashi Y; Furudate S; Kakizaki A; Hidaka T; Haga T; Hashimoto A; Morimoto R; Aiba S
J Dermatol; 2017 Mar; 44(3):e13-e14. PubMed ID: 27440178
[No Abstract] [Full Text] [Related]
13. Scleroderma-like syndrome associated with nivolumab treatment in malignant melanoma.
Cho M; Nonomura Y; Kaku Y; Nakabo S; Endo Y; Otsuka A; Kabashima K
J Dermatol; 2019 Jan; 46(1):e43-e44. PubMed ID: 29863795
[No Abstract] [Full Text] [Related]
14. Lichen sclerosus involving the vagina.
Longinotti M; Schieffer YM; Kaufman RH
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1217-9. PubMed ID: 16260578
[TBL] [Abstract][Full Text] [Related]
15. Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report.
Potter JE; Moore KA
J Gen Intern Med; 2013 Apr; 28(4):592-5. PubMed ID: 22956445
[TBL] [Abstract][Full Text] [Related]
16. Development of Poliosis Following Checkpoint Inhibitor Treatment for Cutaneous Melanoma.
Ediriwickrema LS; Liu CY; Kikkawa DO; Korn BS
Ophthalmic Plast Reconstr Surg; 2019; 35(5):e121-e122. PubMed ID: 31373986
[TBL] [Abstract][Full Text] [Related]
17. An unusual skin reaction in uveal melanoma during treatment with nivolumab: extragenital lichen sclerosus.
Veronesi G; Scarfì F; Misciali C; Tartari F; Melotti B; Patrizi A; Dika E
Anticancer Drugs; 2019 Oct; 30(9):969-972. PubMed ID: 31205068
[TBL] [Abstract][Full Text] [Related]
18. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets.
Pergialiotis V; Bellos I; Biliou EC; Varnava P; Mitsopoulou D; Doumouchtsis SK;
Am J Obstet Gynecol; 2020 Jun; 222(6):542-550.e6. PubMed ID: 31697910
[TBL] [Abstract][Full Text] [Related]
19. Lichen planus in a patient treated with pembrolizumab for metastatic malignant melanoma.
Denny J; Chong H; Akhras V
Clin Exp Dermatol; 2018 Apr; 43(3):354-356. PubMed ID: 29222829
[No Abstract] [Full Text] [Related]
20. A Rare Side Effect of Checkpoint Inhibitor Therapy-Nivolumab-Induced Axial Polyarthritis of the Facet and Costovertebral Joints.
Feist J; Murray A; Skapenko A; Schulze-Koops H
Arthritis Rheumatol; 2019 Nov; 71(11):1823. PubMed ID: 31297971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
